Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125-Reference-Cited by-同舟云学术

Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125

Published:2021-09-29 Issue: Volume: Page:
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Glickman Ariel,Paredes Pilar^ORCID,Carreras-Diéguez Núria,Niñerola-Baizán Aida,Gaba Lydia,Pahisa Jaume,Fusté Pere,del Pino Marta,Díaz-Feijóo Berta,González-Bosquet Eduardo,Agustí Núria,Sánchez-Izquierdo Nuria,Fuster David,Perissinotti Andrés,Romero Inmaculada,Fernández-Galán Esther,Carrasco Josep Lluís,Gil-Ibáñez Blanca,Torné Aureli

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-021-08305-x.pdf

Reference31 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

2. Prat J (2015) Staging Classification for cancer of the ovary, fallopian tube, and peritoneum. Obstet Gynecol 126:171–174. https://doi.org/10.1097/AOG.0000000000000917

3. Vergote I, Tropé CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943–953. https://doi.org/10.1056/NEJMoa0908806

4. Colombo N, Sessa C, Du Bois A et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. https://doi.org/10.1093/annonc/mdz062

5. Chéreau E, Ballester M, Selle F et al (2010) Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol 202:178.e1-178.e10. https://doi.org/10.1016/j.ajog.2009.10.856

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence algorithm for preoperative prediction of FIGO stage in ovarian cancer based on clinical features integrated 18F-FDG PET/CT metabolic and radiomics features;2024-06-26

2. Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125;Gynecologic Oncology;2024-02

3. Predicting epithelial ovarian cancer prognosis: correlation of posttreatment 18F-fluorodeoxyglucose positron emission tomography-computed tomography metabolic parameters, serum carbohydrate antigen, and human epididymis protein levels with overall survival;Quantitative Imaging in Medicine and Surgery;2024-01

4. CT-Based Radiomics for the Preoperative Prediction of Occult Peritoneal Metastasis in Epithelial Ovarian Cancers;Academic Radiology;2023-12

5. Serum Tumor Markers Combined with 18F-FDG PET/CT Volumetric Metabolic Parameters in the Prognosis of Ovarian Cancer;Journal of Biosciences and Medicines;2023